Current diagnostic and therapeutic strategies for the management of lymphatic insufficiency in patients with hypoplastic left heart syndrome

Children with hypoplastic left heart syndrome share unique hemodynamic features that alter lymphatic integrity at all stages of palliation. Lymphatic congestion is almost universal in this patient group to some extent. It may lead to reversal of lymphatic flow, the development of abnormal lymphatic channels and ultimately decompression and loss of protein rich lymphatic fluid into extra lymphatic compartments in prone individuals. Some of the most devastating complications that are associated with single ventricle physiology, notably plastic bronchitis and protein losing enteropathy, have now been proven to be lymphatic in origin. Based on the new pathophysiologic concept new diagnostic and therapeutic strategies have recently been developed. Dynamic contrast magnetic resonance lymphangiography is now mainstay in diagnosis of lymphatic insufficiency and allows a thorough assessment of anatomy and function of the main lymphatic compartments through intranodal, intrahepatic and intramesenteric lymphatic imaging. Contrast enhanced ultrasound can evaluate thoracic duct patency and conventional fluoroscopic lymphangiography has been refined for evaluation of patients where magnetic resonance imaging cannot be performed. Novel lymphatic interventional techniques, such as thoracic duct embolization, selective lymphatic duct embolization and liver lymphatic embolization allow to seal abnormal lymphatic networks minimally invasive and have shown to resolve symptoms. Innominate vein turn-down procedures, whether surgical or interventional, have been designed to reduce lymphatic afterload and increase systemic preload effectively in the failing Fontan circulation. Outflow obstruction can now be managed with new microsurgical techniques that create lympho-venous anastomosis. Short term results for all of these new approaches are overall promising but evidence is sparse and long-term outcome still has to be defined. This review article aims to summarize current concepts of lymphatic flow disorders in single ventricle patients, discuss new emerging diagnostic and therapeutic strategies and point out lacks in evidence and needs for further research on this rapidly growing topic.

[1]  J. Rychik,et al.  Correction to: A Path FORWARD: Development of a Comprehensive Multidisciplinary Clinic to Create Health and Wellness for the Child and Adolescent with a Fontan Circulation , 2022, Pediatric Cardiology.

[2]  Y. Dori,et al.  Lymphatic Disorders in Patients With Single Ventricle Heart Disease , 2022, Frontiers in Pediatrics.

[3]  J. Rychik,et al.  A Path FORWARD: Development of a Comprehensive Multidisciplinary Clinic to Create Health and Wellness for the Child and Adolescent with a Fontan Circulation , 2022, Pediatric Cardiology.

[4]  V. Hjortdal,et al.  Spontaneous contractions of the human thoracic duct—Important for securing lymphatic return during positive pressure ventilation? , 2022, Physiological reports.

[5]  S. Rautiainen,et al.  Contrast-enhanced ultrasound: a new tool for imaging the superficial lymphatic vessels of the upper limb , 2022, European Radiology Experimental.

[6]  Ginger C. Slack,et al.  Novel use of a Synovis™ coupler device for a surgical lymphovenous anastomosis for the treatment of refractory chylothorax in a patient with central lymphatic flow disorder , 2022, Clinical case reports.

[7]  B. Sarubbi,et al.  Protein-losing enteropathy in Fontan circulation: Pathophysiology, outcome and treatment options of a complex condition , 2022, International Journal of Cardiology Congenital Heart Disease.

[8]  Ginger C. Slack,et al.  Novel Use of a Synovis™ Coupler device for a Surgical Lymphovenous Anastomosis for the treatment of refractory Chylothorax in a patient with Central Lymphatic Flow Disorder. , 2021 .

[9]  Lucelli Yáñez-Gutiérrez,et al.  Failures of the Fontan System in Univentricular Hearts and Mortality Risk in Heart Transplantation: A Systematic Review and Meta-Analysis , 2021, Life.

[10]  J. Rome,et al.  Intrahepatic Dynamic Contrast‐Enhanced Magnetic Resonance Lymphangiography: Potential Imaging Signature for Protein‐Losing Enteropathy in Congenital Heart Disease , 2021, Journal of the American Heart Association.

[11]  G. Maleux,et al.  Intranodal Lymphangiography With High-Dose Ethiodized Oil Shows Efficient Results in Patients With Refractory, High-Output Postsurgical Chylothorax: A Retrospective Study. , 2021, AJR. American journal of roentgenology.

[12]  A. Agrafiotis,et al.  Lipiodol lymphangiography as a treatment for refractory postoperative chylothorax: a case report. , 2021, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[13]  V. Hjortdal,et al.  Functional lymphatic reserve capacity is depressed in patients with a Fontan circulation , 2021, Physiological reports.

[14]  M. B. McCarville,et al.  Contrast-Enhanced Ultrasound in Children: Implementation and Key Diagnostic Applications. , 2021, AJR. American journal of roentgenology.

[15]  Y. Dori,et al.  Dynamic contrast-enhanced magnetic resonance lymphangiography , 2021, Pediatric Radiology.

[16]  V. Hjortdal,et al.  Innominate vein turn-down procedure: Killing two birds with one stone , 2021, JTCVS techniques.

[17]  C. Ravishankar,et al.  Fontan‐associated plastic bronchitis waitlist and heart transplant outcomes: A PHTS analysis , 2021, Pediatric transplantation.

[18]  J. Rome,et al.  Lymphatic Disorders and Management in Patients with Congenital Heart Disease. , 2020, The Annals of thoracic surgery.

[19]  J. Windsor,et al.  The Lymphovenous Junction of the Thoracic Duct: A Systematic Review of its Structural and Functional Anatomy. , 2020, Lymphatic research and biology.

[20]  P. Jha,et al.  Isolated Chylopericardium in an Infant With Hypoplastic Left Heart Syndrome , 2020, JACC. Case reports.

[21]  V. Hjortdal,et al.  Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease , 2020, Current Cardiology Reports.

[22]  J. Rome,et al.  Use of Contrast-Enhanced Ultrasound to Determine Thoracic Duct Patency. , 2020, Journal of vascular and interventional radiology : JVIR.

[23]  R. Mair,et al.  Thoracic duct decompression and jugular vein banding—an effective treatment option for protein-losing enteropathy and plastic bronchitis in severe failing Fontan circulation: a case report , 2020, European heart journal. Case reports.

[24]  W. Saad,et al.  Lymphatic Anatomy and Physiology , 2020, Seminars in Interventional Radiology.

[25]  M. Khaja,et al.  Complications during Lymphangiography and Lymphatic Interventions , 2020, Seminars in Interventional Radiology.

[26]  K. Ryan,et al.  Abnormal pulmonary lymphatic flow in patients with paediatric pulmonary lymphatic disorders: Diagnosis and treatment. , 2020, Paediatric respiratory reviews.

[27]  L. M. Harteveld,et al.  Treatment and outcome of plastic bronchitis in single ventricle patients: a systematic review. , 2020, Interactive cardiovascular and thoracic surgery.

[28]  Y. Dori,et al.  Intramesenteric dynamic contrast pediatric MR lymphangiography: initial experience and comparison with intranodal and intrahepatic MR lymphangiography , 2020, European Radiology.

[29]  Shaobin Yu,et al.  Application of imaging technique in thoracic duct anatomy. , 2020, Annals of palliative medicine.

[30]  S. Hur,et al.  Successful thoracic duct embolisation in a child with recurrent massive pericardial effusion diagnosed as a lymphatic anomaly , 2020, Cardiology in the Young.

[31]  G. Tulzer,et al.  Are children with protein-losing enteropathy after the Fontan operation at increased risk of cytomegalovirus enteropathy? A report of two cases , 2020, Cardiology in the Young.

[32]  A. Albillos,et al.  Fontan protein‐losing enteropathy is associated with advanced liver disease and a proinflammatory intestinal and systemic state , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[33]  P. Rattanawong,et al.  Budesonide for Protein Losing Enteropathy in Patients with Fontan Circulation: A Systematic Review and Meta-Analysis , 2020, World journal for pediatric & congenital heart surgery.

[34]  M. Fogel,et al.  Protein Losing Enteropathy After Fontan Operation: Glimpses of Clarity Through the Lifting Fog , 2020, World journal for pediatric & congenital heart surgery.

[35]  K. Olthoff,et al.  Fontan-Associated Liver Disease , 2017, Circulation.

[36]  V. Hraška,et al.  Innominate Vein Turn-down Procedure for Failing Fontan Circulation. , 2020, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[37]  J. Rome,et al.  Decompression of the thoracic duct: A novel transcatheter approach , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[38]  G. Lewis,et al.  Emerging Role of Lymphatics in the Regulation of Intestinal Lipid Mobilization , 2020, Frontiers in Physiology.

[39]  P. Chaffanjon,et al.  Anatomical variations in distal portion of the thoracic duct—A systematic review , 2020, Clinical anatomy.

[40]  M. Gewillig,et al.  Percutaneous embolization of lymphatic fistulae as treatment for protein‐losing enteropathy and plastic bronchitis in patients with failing Fontan circulation , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[41]  J. Rome,et al.  Pediatric pulmonary lymphatic flow Disorders: Diagnosis and management. , 2019, Paediatric respiratory reviews.

[42]  L. Levin,et al.  Thoracic duct-to-vein anastomosis for the management of thoracic duct outflow obstruction in newborns and infants: a CASE series. , 2019, Journal of pediatric surgery.

[43]  Y. D'udekem,et al.  Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. , 2019, Circulation.

[44]  M. Fogel,et al.  MRI Evaluation of Lymphatic Abnormalities in the Neck and Thorax after Fontan Surgery: Relationship with Outcome. , 2019, Radiology.

[45]  V. Hjortdal,et al.  Morphology and Function of the Lymphatic Vasculature in Patients With a Fontan Circulation , 2019, Circulation. Cardiovascular imaging.

[46]  J. Rome,et al.  Intrahepatic dynamic contrast MR lymphangiography: initial experience with a new technique for the assessment of liver lymphatics , 2019, European Radiology.

[47]  J. Upton,et al.  Lymphaticovenous bypass of the thoracic duct for the treatment of chylous leak in central conducting lymphatic anomalies. , 2019, Journal of pediatric surgery.

[48]  A. Eichmann,et al.  The Intestinal Lymphatic System: Functions and Metabolic Implications , 2018, Cellular and molecular gastroenterology and hepatology.

[49]  Anna E. Rutherford,et al.  Hemodynamic Effects of Paracentesis in a Patient With a Fontan Circulation , 2018, World journal for pediatric & congenital heart surgery.

[50]  Christine E. Peyton Protein‐Losing Enteropathy and Plastic Bronchitis After the Fontan Operation , 2018, Critical care nurse.

[51]  K. Darge,et al.  Validation of the Position of Injection Needles with Contrast-Enhanced Ultrasound for Dynamic Contract-Enhanced MR Lymphangiography. , 2018, Journal of vascular and interventional radiology : JVIR.

[52]  J. Windsor,et al.  The anatomy and physiology of the terminal thoracic duct and ostial valve in health and disease: potential implications for intervention , 2018, Journal of anatomy.

[53]  L. Qiu,et al.  A preliminary study , 2018, Medicine.

[54]  Y. D'udekem,et al.  Clinical Outcomes in Adolescents and Adults After the Fontan Procedure. , 2018, Journal of the American College of Cardiology.

[55]  Dean Y. Huang,et al.  Contrast-enhanced ultrasound (CEUS) in abdominal intervention , 2018, Abdominal Radiology.

[56]  G. Koh,et al.  Organ-specific lymphatic vasculature: From development to pathophysiology , 2018, The Journal of experimental medicine.

[57]  G. V. van Arsdell,et al.  CONGENITAL : FONTAN Chylothorax and pleural effusion in contemporary extracardiac fenestrated fontan completion , 2018 .

[58]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[59]  S. R. Kumar Immune System in Single Ventricle Patients—A Complex Nexus , 2017, World journal for pediatric & congenital heart surgery.

[60]  L. Kovacikova,et al.  Immune Abnormalities in Patients With Single Ventricle Circulation Precede the Fontan Procedure , 2017, World journal for pediatric & congenital heart surgery.

[61]  G. Kreutzer,et al.  The Lymphatic System: The Achilles Heel of the Fontan-Kreutzer Circulation , 2017, World journal for pediatric & congenital heart surgery.

[62]  J. Berry,et al.  The thoracic duct and the Fontan patient , 2017, Echocardiography.

[63]  J. Rychik,et al.  Effect of Fontan-Associated Morbidities on Survival With Intact Fontan Circulation. , 2017, The American journal of cardiology.

[64]  J. Rossano,et al.  Post-Operative Chylothorax in Patients With Congenital Heart Disease. , 2017, Journal of the American College of Cardiology.

[65]  D. Winlaw,et al.  The Lymphatic Circulation in Adaptations to the Fontan Circulation , 2017, Pediatric Cardiology.

[66]  Y. Dori Novel Lymphatic Imaging Techniques. , 2016, Techniques in vascular and interventional radiology.

[67]  R. Ichord,et al.  Cerebral Lipiodol Embolism after Lymphatic Embolization for Plastic Bronchitis. , 2016, The Journal of pediatrics.

[68]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[69]  J. Fragata,et al.  Thoracic Duct Decompression for Protein-Losing Enteropathy in Failing Fontan Circulation. , 2016, The Annals of thoracic surgery.

[70]  J. Rychik,et al.  Risk Factors and Clinical Significance of Lymphopenia in Survivors of the Fontan Procedure for Single-Ventricle Congenital Cardiac Disease. , 2016, The journal of allergy and clinical immunology. In practice.

[71]  J. Rychik,et al.  Percutaneous Lymphatic Embolization of Abnormal Pulmonary Lymphatic Flow as Treatment of Plastic Bronchitis in Patients With Congenital Heart Disease , 2016, Circulation.

[72]  Jack Rychik,et al.  The Relentless Effects of the Fontan Paradox. , 2016, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[73]  M. Itkin,et al.  Lymphatic Anatomy. , 2016, Techniques in vascular and interventional radiology.

[74]  C. Hawkins,et al.  Retrograde Thoracic Duct Embolization in a Pediatric Patient with Total Cavopulmonary Connection and Plastic Bronchitis. , 2015, Journal of vascular and interventional radiology : JVIR.

[75]  N. Sreeram,et al.  Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients , 2015, Cardiology in the Young.

[76]  J. Minocha,et al.  Cerebral Embolization of Ethiodized Oil following Intranodal Lymphangiography , 2015, Seminars in Interventional Radiology.

[77]  P. Podolec,et al.  Iron deficiency and hematological changes in adult patients after Fontan operation. , 2014, Journal of cardiology.

[78]  J. Rychik,et al.  Successful Treatment of Plastic Bronchitis by Selective Lymphatic Embolization in a Fontan Patient , 2014, Pediatrics.

[79]  M. Zviman,et al.  Dynamic contrast-enhanced MR lymphangiography: feasibility study in swine. , 2014, Radiology.

[80]  J. Rychik,et al.  Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation , 2014, Heart.

[81]  M. Bowman,et al.  Review of thoracic duct anatomical variations and clinical implications , 2014, Clinical anatomy.

[82]  M. Jacobs,et al.  Procedure-based complications to guide informed consent: analysis of society of thoracic surgeons-congenital heart surgery database. , 2014, The Annals of thoracic surgery.

[83]  E. Blume,et al.  Risk Factors and Outcome of Fontan‐Associated Plastic Bronchitis: A Case‐Control Study , 2014, Journal of the American Heart Association.

[84]  I. Carloni,et al.  Management of plastic bronchitis with nebulized tissue plasminogen activator: another brick in the wall , 2014, Italian Journal of Pediatrics.

[85]  C. Fraser,et al.  Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. , 2014, The Journal of thoracic and cardiovascular surgery.

[86]  K. Stringer,et al.  Pharmacotherapy Challenges of Fontan‐Associated Plastic Bronchitis: A Rare Pediatric Disease , 2013, Pharmacotherapy.

[87]  V. Hraška Decompression of thoracic duct: new approach for the treatment of failing Fontan. , 2013, The Annals of thoracic surgery.

[88]  J. Hirsch,et al.  Demographic Characteristics and Estimated Prevalence of Fontan-Associated Plastic Bronchitis , 2013, Pediatric Cardiology.

[89]  M. Witte,et al.  Successful treatment of plastic bronchitis with low fat diet and subsequent thoracic duct ligation in child with fontan physiology. , 2012, Lymphology.

[90]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[91]  K. Alitalo,et al.  The lymphatic vasculature in disease , 2011, Nature Medicine.

[92]  M. Russell,et al.  Oral Budesonide Treatment for Protein-Losing Enteropathy in Fontan-Palliated Patients , 2011, Pediatric Cardiology.

[93]  P. Cogo,et al.  Orthotopic Heart Transplantation in Patients with Univentricular Physiology , 2011, Current cardiology reviews.

[94]  G. Krombach,et al.  Effectiveness of therapeutic lymphography on lymphatic leakage , 2011, Acta radiologica.

[95]  M. Itkin,et al.  Thoracic duct embolization for chylous leaks. , 2011, Seminars in interventional radiology.

[96]  G. Schembri,et al.  Killing two birds with one stone , 2011, The Lancet.

[97]  B. Preston,et al.  Case Series , 2010, Toxicologic pathology.

[98]  J. Hampe,et al.  Terminal part of thoracic duct: high-resolution US imaging. , 2009, Radiology.

[99]  Jack Rychik,et al.  Protein-losing enteropathy after Fontan operation. , 2007, Congenital heart disease.

[100]  R. Thiagarajan,et al.  Outcome after Fontan failure and takedown to an intermediate palliative circulation. , 2007, The Annals of thoracic surgery.

[101]  S. Berger,et al.  Medical Management of the Failing Fontan , 2007, Pediatric Cardiology.

[102]  J. Skandalakis,et al.  Anatomy of the lymphatics. , 2007, Surgical oncology clinics of North America.

[103]  D. Hsu,et al.  Cardiac transplantation after the Fontan or Glenn procedure. , 2004, Journal of the American College of Cardiology.

[104]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[105]  Jack Rychik,et al.  Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. , 2002, The American journal of cardiology.

[106]  J. R. Lapa e Silva,et al.  Another brick in the wall. , 2002, Sao Paulo medical journal = Revista paulista de medicina.

[107]  Guy E. Thwaites,et al.  The Diagnosis and Management of Tuberculous Meningitis , 2002, Practical Neurology.

[108]  L. Benson,et al.  Chylopericardium after cardiac operations in children. , 2001, The Annals of thoracic surgery.

[109]  S. Nicolson,et al.  Improved early results with cavopulmonary connections , 2001, Cardiology in the Young.

[110]  I. Bendayán,et al.  Heparin Therapy and Reversal of Protein-Losing Enteropathy in a Case with Congenital Heart Disease , 2000, Pediatric Cardiology.

[111]  C. Cope Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. , 1998, Journal of vascular and interventional radiology : JVIR.

[112]  D. Driscoll,et al.  Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease. , 1998, Mayo Clinic proceedings.

[113]  D. Hagler,et al.  Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. , 1998, The Journal of thoracic and cardiovascular surgery.

[114]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[115]  P A Dekker-de Kiefte,et al.  Diagnosis and Treatment , 2020, Diabetes.

[116]  P. Freedson,et al.  Scientific Statement From the American Heart Association Guide to the Assessment of Physical Activity: Clinical and Research Applications: A , 2015 .